Differential reactivities of four homogeneous assays for LDL-cholesterol in serum to intermediate-density lipoproteins and small dense LDL: Comparisons with the Friedewald equation

Clinica Chimica Acta

Volumn 410, Issue 1-2, 2009, Pages 31-38

  Yamashita, Shizuya ^a   Kawase, Ryota ^a   Nakaoka, Hajime ^a   Nakatani, Kazuhiro ^a   Inagaki, Miwako ^a   Yuasa Kawase, Miyako ^a   Tsubakio Yamamoto, Kazumi ^a   Sandoval, Jose C ^a   Masuda, Daisaku ^a   Ohama, Tohru ^a   Nakagawa Toyama, Yumiko ^a,b   Matsuyama, Akifumi ^c   Nishida, Makoto ^a,b   Ishigami, Masato ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

Homogeneous assay; Intermediate density lipoproteins; LDL cholesterol; Small dense LDL; Type III hyperlipoproteinemia

Indexed keywords

INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; HYPERLIPOPROTEINEMIA TYPE 3; INTERMETHOD COMPARISON; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ADULT; AGED; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERLIPOPROTEINEMIA TYPE III; LABORATORY TECHNIQUES AND PROCEDURES; LIPOPROTEINS; LIPOPROTEINS, IDL; LIPOPROTEINS, LDL; MIDDLE AGED; MODELS, THEORETICAL;

EID: 70350782328     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.010     Document Type: Article

References (41)

1. Grundy S.M. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease. Clin Chem 41 (1995) 139-146
2. Gordon T., Kannel W.B., Castelli W.P., and Dawber T.R. Lipoproteins, cardiovascular disease and death. The Framingham study. Arch Interm Med 141 (1981) 1128-1130
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
4. Hatch F.T., and Lees R.S. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 6 (1968) 1-68
5. Bachorik P.S. Measurement of low-density-lipoprotein cholesterol. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of Lipoprotein Testing. 2nd ed. (2000), AACC Press, Washington, DC 245-265
6. Nauck M., Wiebe D., and Warnick G.R. Measurement of high-density-lipoprotein cholesterol. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of Lipoprotein Testing. 2nd ed. (2000), AACC Press, Washington, DC 221-244
7. Bachorik P.S., and Ross J.W. National cholesterol education program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The national cholesterol education program working group on lipoprotein measurement. Clin Chem 41 (1995) 1414-1420
8. Myers G.L., Cooper G.R., Greenberg N., Kimberly M.M., Waymack P.P., and Hassemer D.J. Standardization of lipid and lipoprotein measurements. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of Lipoprotein Testing. 2nd ed. (2000), AACC Press, Washington, DC 717-748
9. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
10. Nauck M., Winkler K., März W., and Wieland H. Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein (a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin Chem 41 (1995) 1761-1767
11. Carroll R.M., and Rudel L.L. Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gel-filtration chromatography. J Lipid Res 24 (1983) 200-207
12. Kramer M.A. Forcus on cholesterol research (2005), Nova Science Publishers, Inc., New York 113-146
13. Hainline A, Jr, Karon J, Lippel K, eds. Manual of labolatory operations: lipidand lipoprotein analysis, 2ed ed. [HEW Pub. No. (NIH) 75-628 (rev.), U.S. Government Printing Office Publication No. 1982-361-132:678.] Bethesda, MD: National Heart, Lung, and Blood Institute, Lipid Research Clinics Program.
14. Rifai N., Warnick G.R., McNamara J.R., Belcher J.D., Grinstead G.F., and Frantz Jr. I.D. Measurement of low-density lipoprotein cholesterol in serum: a status report. Clin Chem 38 (1992) 150-160
15. Wilson P., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
16. Cobain M.R., Pencina M.J., D'Agostino R.B., and Vasan R.S. Lifetime risk for developing dyslipidemia: the Framingham offspring study. Am J Med 120 (2007) 623-630
17. Nauck M., Warnick G.R., and Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 48 (2002) 236-254
18. Hodis H.N., Mack W.J., Dunn M., Liu C., Selzer R.H., and Krauss R.M. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Circulation 95 (1997) 2022-2026
19. Nauck M., Graziani M.S., Bruton D., Cobbaert C., Cole T.G., Lefevre F., et al. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem 46 (2000) 506-514
20. Fei H., Maeda S., Kirii H., Fujigaki S., Maekawa N., Fujii H., et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem 46 (2000) 1351-1356
21. Ordóñez-Llanos J., Wägner A.M., Bonet-Marqués R., Sánchez-Quesada J.L., Blanco-Vaca F., and González-Sastre F. Which cholesterol are we measuring with the Roche direct, homogeneous LDL-C plus assay?. Clin Chem 47 (2001) 124-126
22. Iwasaki Y., Matsuyama H., and Nakashima N. Improved specificity of a new homogeneous assay for LDL-cholesterol in serum with abnormal lipoproteins. Clin Chem 52 (2006) 886-888
23. Kameda K., Matsuzawa Y., Kubo M., Ishikawa K., Maejima I., Yamamura T., et al. Increased frequency of lipoprotein disorders similar to type III hyperlipoproteinemia in survivors of myocardial infarction in Japan. Atherosclerosis 51 (1984) 241-249
24. Mishima Y., Ando M., Kuyama A., Ishioka T., and Kibata M. A simple method for identifying particle size of low-density lipoprotein using PAG electrophoresis: comparison between LipoPhorTM and LipoPrint LDLTM systems. J Jpn Atheroscler Soc 25 (1997) 67-70
25. Hirano T., Ito Y., and Yoshino G. Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb 12 (2004) 67-72
26. Blamd J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
27. Yanai H. Statcel: the useful add-in software forms on Excel. 2nd ed. (2004), OMS, Tokyo
28. Wikinski R.L., Schreier L.E., and Rosental S.B. New method for isolating and quantifying intermediate and β-very-low-density lipoprotein cholesterol. Clin Chem 37 (1991) 1913-1916
29. Mahley R.W., and Rall Jr. S.C. Type III hyperlipoproteinemia (Dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver C.R., Beaudet A.L., and Sly W.S. (Eds). The metabolism and molecular bases of inherited disease. 8th ed. (2001), McGraw-Hill, New York 2835-2862
30. Todo Y., Kobayashi J., Higashikata T., Kawashiri M., Nohara A., Inazu A., et al. Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype. Clin Chim Acta 348 (2004) 35-40
31. Vergès B., Florentin E., Baillot-Rudoni S., Monier S., Petit J.M., Rageot D., et al. Effect of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes. Diabetologia 51 (2008) 1382-1390
32. Havel R.J., and Kane J.P. Introduction: structure and meabolism of pasma lioproteins. In: Scriver C.R., Beaudet A.L., and Sly W.S. (Eds). The Metabolism and Molecular Bases of Inherited Disease. 8th ed. (2001), McGraw-Hill, New Tork 2705-2716
33. Sugiuchi H., Irie T., Uji Y., Ueno T., Chaen T., Uekama K., et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate. Clin Chem 44 (1998) 522-531
34. Miller W.G., Waymack P.P., Anderson P., Ethridge S.F., and Jayne E. Performance of 4 homogeneous direct methods for LDL-cholesterol. Clin Chem 48 (2002) 489-498
35. Yanagi K., Yamashita S., Kihara S., Nakamura T., Nozaki S., Nagai Y., et al. Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose tolerance. Atherosclerosis 132 (1997) 43-51
36. Krauss R.M., Lindgren F.T., Williams P.T., Kelsey S.F., Brensike J., Vranizan K., et al. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 2 (1987) 62-66
37. Phillips N.R., Waters D., and Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88 (1993) 2762-2770
38. Galeano N.F., Milne R., Marcel Y.L., Walsh M.T., Levy E., Ngu'yen T.D., et al. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) in modified in small LDL, but not in triglyceride rich LDL of normal size. J Biol Chem 269 (1994) 511-519
39. McNamara J.R., Small D.M., Li Z., and Schaefer E.J. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res 37 (1996) 1924-1935
40. De Graaf J., Hak-Lammers H.L., Hectors M.P., Demacker P.N., Hendriks J.C., and Stalenhoef A.F. Enhanced susceptibility to in vivo oxidation of the dense low density lipoprotein subfraction in heasthy subjects. Arterioscler Thromb 11 (1991) 298-306
41. Dejager S., Bruckert E., and Chapman M.J. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 34 (1993) 295-308